Home › Targets › EphA2

EphA2 (1 companies · 2 programs)

Companies with an active program directed at EphA2.

BICYCLE THERAPEUTICS PLC BCYC

  • nuzefatide pevedotin — Pancreatic Ductal Adenocarcinoma Phase 2
  • nuzefatide pevedotin — Urothelial Cancer Phase 1